The European Union (EU) has been a donor to Gavi since 2003, with increasing financial and political support. Building up immunisation systems is a fundamental part of the work the EU does with Gavi and partner countries to strengthen health systems.
The EU is a strong supporter of Gavi and the Gavi COVAX AMC, demonstrating global solidarity through a commitment to access to vaccines throughout the pandemic. In 2020, President von der Leyen announced a contribution of €100 million in grant funding to the Gavi COVAX AMC and €400 million in guarantees from the European Investment Bank (EIB), as part of the EU’s Global Coronavirus Response. This supported the Gavi COVAX AMC to secure access to COVID-19 vaccines for lower- and middle-income countries.
At the G7 Summit in February 2021, as a mark of the EU’s staunch support for Gavi and COVAX, this financial support to the Gavi COVAX AMC was doubled, with an additional €300 million in grant funding and an additional €200 million for a frontloading facility through the EIB. In June 2021, at the Gavi COVAX AMC Summit, President von der Leyen announced €300 million in cost-sharing support through EIB guarantees.
In 2022, the EU responded to the needs of countries requiring support for vaccine delivery and roll-out. Commissioner Urpilainen announced €75 million towards vaccine delivery at the Gavi COVAX AMC Summit in April. This support was complemented by the EIB’s President, Dr Werner Hoyer, pledging an additional €1 billion of flexible liquidity to support the Gavi COVAX AMC. President von der Leyen increased the EU’s commitment to vaccine delivery and roll-out with an additional €300 million for the Gavi COVAX AMC, announced at the Global COVID-19 Summit co-hosted by the United States, Belize, Germany, Indonesia and Senegal in May 2022.
The European Commission has supported the COVAX dose donation mechanism, helping to coordinate the dose donations of European Member States. Team Europe has donated more than 400 million COVID-19 doses to COVAX, increasing global access.
The EU, represented by the European Commission, has taken an active role in supporting Gavi’s core mission to increase equitable use of vaccines. On 4 June 2020, at the Global Vaccine Summit, President von der Leyen pledged €300 million to Gavi for the 2021–2025 period, marking a 50% increase in the Commission’s commitment compared to the previous period.
Together with Gavi COVAX AMC funding and EIB guarantees, the EU has committed around €3 billion in financing to Gavi in total during this period, an incredible commitment to global solidarity.
In May 2014 the European Commission held an event to launch Gavi’s second replenishment and increased the EU’s contribution to Gavi to €175 million for the period 2016–2020. This commitment was increased to a total of €200 million at the replenishment conference in Berlin the following year. This marked a substantial (threefold) increase from the previous financing period. The contribution comprised €70 million from the Development Co-operation Instrument (DCI) and €130 million from the intra-ACP envelope of the European Development Fund (EDF). The European Commission contributed US$ 58 million between 2003 and 2010. At Gavi’s pledging conference in June 2011, the EU committed an additional €10 million to Gavi from the DCI and EDF financing instruments.
Proceeds are funds made available to Gavi from donor contributions and commitments, either through cash payments made to Gavi, through frontloading via the capital markets of a future donor commitment to IFFIm, or through AMC funds released to Gavi via the World Bank. IFFIm proceeds are allocated over five-year periods coinciding with Gavi’s strategic periods. Proceeds for the current and future strategic periods are indicative until the end of each period and could be revised following changes in market conditions (interest rates or foreign exchange rates), the signing of new pledge(s) and/or changes in IFFIm’s disbursement profile.
Click on Direct, IFFIm, AMC or Matching Fund in the above key to toggle their data on the graph, click again to show the data
Direct Contributions (including Matching Fund)
Received contributions: non-US$ contributions for 2000–2022 and Q1-Q2 2023 are expressed in US$ equivalents using the exchange rates on the dates of receipt. For 2014–2022 and Q1-Q2 2023 where contributions were hedged to mitigate currency risk exposure, these have been expressed using the rates applicable to the hedge agreement.
Future contributions (for pledges made prior to the June 2020 donor pledging conference): non-US$ Direct Contribution and Matching Fund pledges for Q3-Q4 2023 and for years 2024 and beyond are expressed in US$ equivalents using the applicable forecast rates from Bloomberg as at 30 June 2023 or using the rates applicable to any hedge agreement in place.
Future contributions (for pledges at the June 2020 donor pledging conference): non-US$ Direct Contribution and Matching Fund pledges for Q3-Q4 2023 and for years 2024 and beyond are expressed in US$ equivalents using the spot rates from Refinitiv as at 30 June 2023 or using the rates applicable to any hedge agreement in place.
Received contributions: non-US$ contributions for 2000-2022 and Q1-Q2 2023 are expressed in US$ equivalents as confirmed by the IBRD (World Bank)
Future contributions: non-US$ Direct Contribution and Matching Fund pledges for Q3-Q4 2023 and for years 2024 and beyond are expressed in US$ equivalents using the applicable forecast rates from Bloomberg as at 30 June 2023 or using the rates applicable to any hedge agreement in place.
Due to IFFIm’s nature as a frontloading vehicle, yearly contributions paid into IFFIm can differ significantly from yearly proceeds transferred to Gavi.
While IFFIm grants are irrevocable and legally binding, they are subject to a Grant Payment Condition that can potentially reduce the amount due by the donor in the event that a Gavi-supported programme country is in protracted arrears with the International Monetary Fund. Since 29 June 2021, there is no longer any reduction applied, as all countries from the reference portfolio have cleared their arrears with the IMF.